PROFESSIONAL EDITION

The largest community of pharma leaders

Newsletters

GenSight Biologics Appoints Françoise de Craecker to its Board of Directors

PARIS--(BUSINESS WIRE)--Regulatory News: GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative...

Memo Therapeutics AG Antibodies Against SARS-CoV-2 Show Efficacy Against British and South African Variant

SCHLIEREN, Switzerland--(BUSINESS WIRE)--Memo Therapeutics AG (“Memo”), an innovator in the field of antibody discovery and development, announced today that MTX-COVAB, its human-derived antibody against...

PrecisionLife and Cyclica Sign Strategic Partnership Combining Leading Data-driven Biology and Chemistry Platforms to Create a Rapid Innovation Engine for Drug Discovery

OXFORD, England & TORONTO--(BUSINESS WIRE)--PrecisionLife Ltd. (“PrecisionLife”), the leading combinatorial analytics company driving understanding of disease biology and patient stratification, and Cyclica Inc. (“Cyclica”),...

AavantiBio Rounds Out Leadership Team with Appointment of Jessie Hanrahan, Ph.D. as Chief Regulatory Officer

CAMBRIDGE, Mass.--(BUSINESS WIRE)--AavantiBio, a gene therapy company focused on transforming the lives of patients with rare genetic diseases, today announced the appointment of Jessie...

Centessa Pharmaceuticals Announces Expansion of Management Team and Board of Directors

CAMBRIDGE, Mass. & LONDON--(BUSINESS WIRE)--Centessa Pharmaceuticals (“Centessa”) today announced key additions to its leadership team and Board of Directors. Centessa has appointed Tia Bush,...

Recent Articles